The Array 5 – Multiple Autoimmune Reactivity Screen from Cyrex Laboratories assesses autoantibodies predictive for certain diseases. It determines potential tissue damage in various body organs, including cardiovascular, endocrine, joint, gastrointestinal, and neurological. Early detection of autoimmunity is helpful in potentially halting or reversing disease progression.

The Array 5 – Multiple Autoimmune Reactivity Screen measures Predictive Antibodies and self-targeting indicators for acquiring particular autoimmune diseases in the future.

As the Array 5 – Multiple Autoimmune Reactivity Screen produces results that can predict some illnesses up to 10 years in advance.

It is a beneficial test for patients with a diagnosed autoimmune condition, those at risk for developing autoimmune diseases, or patients with chronic increased intestinal permeability with potential for environmentally-induced autoimmune issues.

Some common patient types this test is beneficial for are:

• Addison’s disease
• Chronic fatigue syndrome
• Diabetes
• Fibromyalgia
• Grave’s
• Inflammatory Bowel Disease
• Lupus
• Rheumatoid arthritis